Pioglitazone attenuates complement-mediated microglial synaptic engulfment in an Alzheimer’s disease model - Summary - MDSpire

Pioglitazone attenuates complement-mediated microglial synaptic engulfment in an Alzheimer’s disease model

  • By

  • Juan Zu

  • Cong Li

  • Mochen Cui

  • Xinwu Liu

  • Zhouyang Pan

  • Xiaohe Li

  • Fang Zhang

  • Johanna Gentz

  • Gerda Mitteregger-Kretzschmar

  • Jochen Herms

  • Yuan Shi

  • December 15, 2025

  • 0 min

Share

Objective:

Consider adding a hypothesis or expected outcomes.

Key Findings:
  • Expand with specific data or metrics.
Interpretation:

Emphasize implications for future research.

Limitations:
  • Be more specific about the impact on conclusions.
Conclusion:

Reiterate broader impact on Alzheimer's treatment.

Original Source(s)

Pioglitazone attenuates complement-mediated microglial synaptic engulfment in an Alzheimer’s disease model

  • by Juan Zu, Cong Li, Mochen Cui, Xinwu Liu, Zhouyang Pan, Xiaohe Li, Fang Zhang, Johanna Gentz, Gerda Mitteregger-Kretzschmar, Jochen Herms, Yuan Shi

  • December 15, 2025

Related Content

Open Your Eyes and Eliminate Bad Stress, Starting Now

Drawing on Blue Zones research, Dr. Jasper lists tips to manage stress and overall health.

Predictive value of Galectin-3 in cognitive impairment: a systematic review and meta-analysis

Associations of Individual- and Neighborhood-Level Factors with Racial and Ethnic Disparities in Timely Dementia Diagnosis